New Weight Loss Drug Retatrutide Delivers Stunning Results

6 sources covered this compare →

Coverage diverges in the emphasis placed on the drug's effectiveness and implications. TODAY.com highlights the "stunning" results and compares retatrutide favorably to existing GLP-1 medications, while the Washington Examiner focuses on…

May 21, 2026 · 12:04 PM UTC ·1 min read · 0 reactions · 0 comments · 13 views

#health #pharmaceuticals #weight loss

New Weight Loss Drug Retatrutide Delivers Stunning Results

⚡ TL;DR · AI summary

Eli Lilly's new weight loss drug, retatrutide, shows promising results in recent trials. It may surpass the effectiveness of existing GLP-1 medications. Experts are discussing the potential timeline for FDA approval.

Key facts

▪Retatrutide is designed to mimic three hormones that regulate hunger and fat burning.
▪The drug has shown remarkable test results, indicating it may be more effective than current GLP-1s.
▪Medical experts are analyzing the trial results and the likelihood of FDA approval.

Original article

TODAY.com

Read full at TODAY.com →

Opening excerpt (first ~120 words) tap to expand

CopiedRemarkable new test results by drugmaker Eli Lilly reveal that their latest weight loss drug, retatrutide, may be even more effective than the three popular GLP-1s currently available. The new drug is designed to mimic three hormones responsible for hunger regulation and fat burning. NBC’s medical contributor Dr. Natalie Azar breaks down the trial results and discusses how soon the new drug is likely to get FDA approval.May 21, 2026

Excerpt limited to ~120 words for fair-use compliance. The full article is at TODAY.com.

Anonymous · no account needed

Discussion

0 comments

New Weight Loss Drug Retatrutide Delivers Stunning Results

Discussion

More from TODAY.com